Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00061529 · ClinicalTrials.gov registry record · Phase 3
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00061529 is a Phase 3 study that has completed, run by Alcon Research.
The verdict
NCT00061529, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The primary objective of this study is to compare the safety and efficacy of Brimonidine Tartrate Ophthalmic Solution, 0.15% in patients with open-angle glaucoma or ocular hypertension.
Interventions
- DRUG Brimonidine Tartrate Ophthalmic Solution
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-01 |
| Est. Completion | 2004-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00061529
The ClinicalTrials.gov registry entry for NCT00061529 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brimonidine Tartrate Ophthalmic Solution is the first listed.
NCT00061529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00061529 about?
NCT00061529 is a clinical study titled "A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension". The primary objective of this study is to compare the safety and efficacy of Brimonidine Tartrate Ophthalmic Solution, 0.15% in patients with open-angle glaucoma or ocular hypertension.
What is the current status of trial NCT00061529?
This trial is currently completed. It is a Phase 3 study. The study started on 2003-01. Estimated completion is 2004-07.
What interventions are being tested in trial NCT00061529?
The interventions under investigation include: Brimonidine Tartrate Ophthalmic Solution (DRUG).
Who is sponsoring clinical trial NCT00061529?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.